• TNBC0
• HER 2+0
• HR+/HER2 neg1
• ER+1

• Protocols

• UW21125

  OPEN TO ACCRUAL

  Ph 1 Study of Denikitug alone and with Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors
  
  

• UW23151

  OPEN TO ACCRUAL

  Ph 1 Study of SynKIR-110, CAR-T Therapy in Pts w/ MSLN-Expressing OC, CCA, or Mesothelioma